41
panel
COVID-19 Presses the Accelerator on Biomedical R&D
COVID-19 has exposed many fault lines that FasterCures identifies as brakes on progress in biome
dical R&D even in the best of times.
+ Read More
panel
Gaps Amid the Progress: Uncovering Blind Spots that Persist in Patient Centric Research (Invite only)
This workshop brings together thought leaders from the FasterCures community to identify persist
ent gaps preventing full engagement of patients in R&D and post-drug-approval efforts.
+ Read More
panel
An Intimate Gathering of Global Health Leaders (Invite only)
On behalf of FasterCures Advisory Board member Dr. Annalisa Jenkins and Sir Michael Hintze, we w
ould like to invite you to join us for a private reception at the Beverly Wilshire.
+ Read More
panel
Part 1: A Conversation with FDA Commissioner Stephen Hahn | Part 2: Health Innovation: Improving Patient Access and Information
This session will open with a conversation with Stephen Hahn, Commissioner, US Food and Drug Adm
inistration, followed by a panel discussion.
+ Read More
panel
Part 1: A Conversation with Rep. Anna Eshoo | Part 2: Unseen Burdens: Managing Chronic Disease During COVID-19 and Beyond
This session will begin with a conversation with US Representative, California, Anna Eshoo follo
wed by a panel discussion.
+ Read More